20 results on '"Anastasiou, Panayiotis"'
Search Results
2. Antibodies against endogenous retroviruses promote lung cancer immunotherapy
3. Spatial proteomic analysis of a lung cancer model reveals regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses
4. Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution
5. Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold tumours hot
6. 871 Combining KRASG12C(ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour immunity in lung cancer
7. In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer
8. Abstract 5733: Combining KRASG12C(ON) inhibition with SHP2 and immune checkpoint blockade to enhance anti-tumor immunity and overcome development of resistance in lung cancer
9. Figure S10 from MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
10. Data from MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
11. Table S1 from MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
12. Antibodies against endogenous retroviruses promote lung cancer immunotherapy
13. Therapeutic KRAS G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
14. Abstract 4029: Combination of KRASG12C(ON) and SHP2 inhibitors overcomes adaptive resistance and enhances anti-tumor immunity
15. Therapeutic KRASG12C inhibition drives effective interferon-mediated anti-tumour immunity in immunogenic lung cancers
16. Preventing cancer by long-term partial Myc suppression
17. MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
18. Myc instructs and maintains pancreatic adenocarcinoma phenotype
19. Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.
20. CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.